NCT04092010

Brief Summary

Within a research network of Head Start centers in Massachusetts, an efficacy trial of a stepped-care intervention (SCI) to address maternal depression, using intervention components that both prevent depression and help those in major depressive episode (MDE) engage with care, will be conducted. Both the prevention and engagement components of the model have strong, supportive randomized trial evidence for both their efficacy and safety; but they have yet to be synthesized and tested within a coordinated intervention, applicable to a broad population base. Stepped-care interventions are commonly used in mental health service projects, in which the intensity or type of service is calibrated to the severity of illness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
388

participants targeted

Target at P75+ for not_applicable

Timeline
24mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Aug 2023Apr 2028

First Submitted

Initial submission to the registry

September 13, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 17, 2019

Completed
3.9 years until next milestone

Study Start

First participant enrolled

August 16, 2023

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2028

Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

4.7 years

First QC Date

September 13, 2019

Last Update Submit

December 6, 2024

Conditions

Keywords

Stepped care interventionProblem solving educationEngagement sessionHead StartPreschool children

Outcome Measures

Primary Outcomes (2)

  • Change in incident rates of moderate to severe maternal depressive symptoms based on the QIDS

    The Quick Inventory of Depressive Symptoms (QIDS) will be used to assess the incidence of moderate to severe depressive symptom episodes, as defined by a QIDS score ≥ 11. The QIDS is a 16 item self-administered instrument with potential responses for each item of 0 to 3. Higher scores are associated with greater depressive symptoms.

    Baseline, 2, 4, 6, 8, 10, 12 months follow-up

  • Change in the mean maternal depressive symptoms based on the QIDS

    The Quick Inventory of Depressive Symptoms will be used to assess depressive symptoms. The QIDS is a 16 item self-administered instrument with potential responses for each item of 0 to 3. Higher scores are associated with greater depressive symptoms. The mean QIDS scores will be calculated for the baseline and each follow up period.

    Baseline, 2, 4, 6, 8, 10, 12 months follow-up

Secondary Outcomes (14)

  • Rate of participants engaged with care based on 1 or more psycho/pharmacotherapy visits or psychiatric medication prescription

    Baseline, 2, 4, 6, 8, 10, 12 months follow-up

  • Rate of participants retained in care based on 4 or more psycho/pharmacotherapy visits or psychiatric medication prescription

    2, 4, 6, 8, 10, 12 months

  • Rate of participants who received evidence-based care defined by psychotherapy or antidepressant medication prescription

    2, 4, 6, 8, 10, 12 months

  • Rate of participants who received primary-care based services

    2, 4, 6, 8, 10, 12 months

  • Burden of illness for depression

    baseline; 6, 12 months

  • +9 more secondary outcomes

Study Arms (2)

Stepped-care intervention (SCI) group

EXPERIMENTAL

In the SCI group, mothers with low baseline depressive symptoms are offered the problem-solving education (PSE) prevention intervention, and mothers with greater depressive symptoms are offered Engagement Sessions.

Behavioral: Problem-solving education (PSE)Behavioral: Engagement sessions

Usual care control group

ACTIVE COMPARATOR

Families in the control group will receive usual Head Start services.

Behavioral: Usual care

Interventions

PSE will be offered to mothers with low baseline depressive symptoms (the first, preventive step of the SCI). PSE participants will have their symptoms assessed at each session and will convert to Engagement Sessions if they meet pre-specified 'step up' criteria.

Stepped-care intervention (SCI) group

Engagement sessions will be offered to mothers with greater depressive symptoms to link them to formal mental health services (the second, referral step of the SCI)

Stepped-care intervention (SCI) group
Usual careBEHAVIORAL

Normal services provided children and their mothers in Head Start

Usual care control group

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Mother of a 0 to 5-year-old Head Start child
  • Mother speaks English or Spanish

You may not qualify if:

  • Mother with suicidal ideation
  • Mother with cognitive limitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Medical Center

Boston, Massachusetts, 02119, United States

RECRUITING

Study Officials

  • Emily Feinberg, ScD CPNP

    Brown University

    PRINCIPAL INVESTIGATOR
  • Michael Silverstein, MD

    Brown University

    PRINCIPAL INVESTIGATOR
  • Amy Yule, MD

    Boston Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jocelyn Antonio, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2019

First Posted

September 17, 2019

Study Start

August 16, 2023

Primary Completion (Estimated)

April 30, 2028

Study Completion (Estimated)

April 30, 2028

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data that underlie the results reported for all primary and secondary outcome measures will be made available (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Beginning 6 months after study completion and ending 5 years following article publication.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee identified for the purposes of reviewing proposals to gain access to these data. Requestors will need to provide a methodologically sound proposal, sign a data sharing agreement, and agree to the terms of data receipt.

Locations